IT9020295A1 - DETERMINATION PROCEDURE FOR IGG ANTI-BODIES SPECIFIC ANTI-ALLERGENS, A FRACTION RICH IN IHG4 OBTAINED ACCORDING TO THIS PROCEDURE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION - Google Patents

DETERMINATION PROCEDURE FOR IGG ANTI-BODIES SPECIFIC ANTI-ALLERGENS, A FRACTION RICH IN IHG4 OBTAINED ACCORDING TO THIS PROCEDURE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION

Info

Publication number
IT9020295A1
IT9020295A1 IT020295A IT2029590A IT9020295A1 IT 9020295 A1 IT9020295 A1 IT 9020295A1 IT 020295 A IT020295 A IT 020295A IT 2029590 A IT2029590 A IT 2029590A IT 9020295 A1 IT9020295 A1 IT 9020295A1
Authority
IT
Italy
Prior art keywords
fraction
procedure
ihg4
allergens
pharmaceutical composition
Prior art date
Application number
IT020295A
Other languages
Italian (it)
Other versions
IT9020295A0 (en
Inventor
Clothilde Bremard-Oury
Patrick Lambin
Original Assignee
Fond Nat Transfusion Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Nat Transfusion Sanguine filed Critical Fond Nat Transfusion Sanguine
Publication of IT9020295A0 publication Critical patent/IT9020295A0/en
Publication of IT9020295A1 publication Critical patent/IT9020295A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
IT020295A 1989-05-12 1990-05-14 DETERMINATION PROCEDURE FOR IGG ANTI-BODIES SPECIFIC ANTI-ALLERGENS, A FRACTION RICH IN IHG4 OBTAINED ACCORDING TO THIS PROCEDURE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION IT9020295A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8906281A FR2646917A1 (en) 1989-05-12 1989-05-12 METHOD FOR DETERMINING ANTI-ALLERGEN SPECIFIC IGG ANTI-BODY, IGG4-RICH FRACTION OBTAINED ACCORDING TO THIS PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION

Publications (2)

Publication Number Publication Date
IT9020295A0 IT9020295A0 (en) 1990-05-14
IT9020295A1 true IT9020295A1 (en) 1990-11-13

Family

ID=9381627

Family Applications (1)

Application Number Title Priority Date Filing Date
IT020295A IT9020295A1 (en) 1989-05-12 1990-05-14 DETERMINATION PROCEDURE FOR IGG ANTI-BODIES SPECIFIC ANTI-ALLERGENS, A FRACTION RICH IN IHG4 OBTAINED ACCORDING TO THIS PROCEDURE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION

Country Status (3)

Country Link
FR (1) FR2646917A1 (en)
IT (1) IT9020295A1 (en)
WO (1) WO1990013817A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
BRPI0800612A2 (en) * 2008-01-02 2009-08-25 Fundacao Fapemig Method and Kit for Quantifying Allergen-Specific Human IgG Subclasses for Follow-Up of Specific Immunotherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228421A (en) * 1984-04-27 1985-11-13 Shionogi & Co Ltd Monoclonal anti-human-igg antibody and its preparation
EP0161868B1 (en) * 1984-05-11 1992-11-04 BioWhittaker, Inc. Fluorometric assay of igg4
FR2578425B1 (en) * 1985-03-07 1988-06-10 Nal Transfusion Sanguine Centr IMMUNOGLOBULIN PREPARATIONS HAVING HIGH TITLES OF ANTI-ALLERGENIC BLOCKING ANTIBODIES, THEIR PREPARATION AND THEIR APPLICATIONS FOR THE TREATMENT OF ALLERGIES
JPS61286754A (en) * 1985-06-12 1986-12-17 Shionogi & Co Ltd Monoclonal anti-human igg4 antibody and its preparation

Also Published As

Publication number Publication date
IT9020295A0 (en) 1990-05-14
WO1990013817A1 (en) 1990-11-15
FR2646917A1 (en) 1990-11-16

Similar Documents

Publication Publication Date Title
NZ236000A (en) Oligomeric monoclonal igg antibody composition
EP0408859A3 (en) Monoclonal antibodies to activated endothelial cells
ZA908521B (en) Vaccine composition with non-immunosuppressive t cell epitope component
AU7095887A (en) Human gamma interferon-specific receptor protein, antibody against said protein and said antibody and compositions containing said protein and antibody
IL105541A0 (en) Monoclonal antibodies to gp130 protein,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0359063A3 (en) Antibody having high affinity to hapten as antigen and immunogen for obtaining the same
GB2196634B (en) Monoclonal antibodies to hiv and related peptides
GB2186592B (en) Cross-protective human monoclonal antibody compositions
NZ234049A (en) Peptide epitopes of, and antibodies to htlv-1
IT9020295A1 (en) DETERMINATION PROCEDURE FOR IGG ANTI-BODIES SPECIFIC ANTI-ALLERGENS, A FRACTION RICH IN IHG4 OBTAINED ACCORDING TO THIS PROCEDURE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION
AU7912887A (en) Monoclonal antibodies to fibrin
IL77990A (en) Monoclonal anti-alpha-amylase antibody,process for obtaining the same and pharmaceutical compositions containing the same
EP0267601A3 (en) Anti-pci monoclonal antibody
AU591579B2 (en) Antibodies for use in determining human glycoalbumin
DE68926774D1 (en) Polypropylene composition
AU8168887A (en) Monoclonal antibodies effective in promoting growth
DK138084A (en) BOND CLOSED COMPOSITION, PRIOR TO PHARMACEUTICAL CONTAINERS
KR900700541A (en) Propylene-ethylene copolymer composition and preparation method thereof
AU680836B2 (en) Human monoclonal antibodies to human immunodeficiency virus
ZA97459B (en) Composition and methods for administering borrelia burgdorferi antigens.
HU896324D0 (en) Peptides binding to antibody
AU5217890A (en) Monoclonal antibodies in vaccine formulations
AU4576689A (en) Peptides which bind to hiv-2 specific antibody
EP0407586A4 (en) Human monoclonal antibody and process for its preparation
AU6861987A (en) Cross-protective human monoclonal antibody compositions

Legal Events

Date Code Title Description
0002 Rejected